famotidine has been researched along with Jejunal Diseases in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Jejunal Diseases: Pathological development in the JEJUNUM region of the SMALL INTESTINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kusunoki, M | 1 |
| Shoji, Y | 1 |
| Okamoto, T | 1 |
| Kusuhara, K | 1 |
| Sakanoue, Y | 1 |
| Utsunomiya, J | 1 |
1 other study available for famotidine and Jejunal Diseases
| Article | Year |
|---|---|
Treatment of high output enterocutaneous fistulas with a somatostatin analogue and famotidine.
Topics: Abscess; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Famotidine; Humans; Ileostomy; I | 1992 |